<?xml version="1.0" encoding="UTF-8"?>
<div id="Fig4" class="fig" xmlns="http://www.w3.org/1999/xhtml">
 <span class="label">Figure 4</span>
 <div class="caption">
  <p>Graphical panel presenting the most relevant interactions involving the pembrolizumab heavy-chain residues. (
   <span class="bold">a</span>) 
   <span class="italic">Y</span>33 and 
   <span class="italic">Y</span>35; (
   <span class="bold">b</span>) 
   <span class="italic">R</span>99, 
   <span class="italic">D</span>100 and 
   <span class="italic">Y</span>101; (
   <span class="bold">c</span>) 
   <span class="italic">R</span>102 and (
   <span class="bold">d</span>) 
   <span class="italic">F</span>103, 
   <span class="italic">M</span>105 and 
   <span class="italic">D</span>108, respectively.
  </p>
 </div>
 <div xlink:href="41598_2018_20325_Fig4_HTML" id="d29e1180" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</div>
